Scrutiny of SAS-B data for psychiatric conditions exposes prescribing ‘disconnect’ by Steve Jones June 7, 2023April 30, 2024 Patients are being prescribed medicinal cannabis for psychiatric conditions where evidence is lacking or unclear, in […]
SAS-B approvals rebound with second highest number of the year by Steve Jones June 5, 2023April 30, 2024
Queensland regains top spot as Australia’s cannabis capital by Steve Jones April 4, 2023April 30, 2024
Queensland loses top spot for SAS-B approvals for first time in four years by Steve Jones March 6, 2023April 30, 2024
SAS-B approvals dip in 2022 following TGA reforms, but patient numbers still climbing by Martin Lane January 9, 2023April 29, 2024
Approvals through SAS-B scheme the third highest this year by Steve Jones December 8, 2022April 29, 2024
How to interpret the TGA’s Authorised Prescriber figures by Rhys Cohen November 17, 2022April 29, 2024
TGA launches AP dashboard as SAS-B approvals remain steady by Steve Jones November 2, 2022April 29, 2024